Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Eton Pharmaceuticals, Inc.

Report pivotal bioequivalence study results for ET-600

Delivered after the deadline (14 days after the deadline)

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
7 Feb 2025
Due
28 Feb 2025
Delivered
14 Mar 2025
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The Company expects to have study results at the end of February.”

What we found

Evidence strength A What the grades mean

Eton announced positive ET-600 pivotal bioequivalence study results on March 14, 2025, about two weeks after the stated end-of-February deadline.

Checked 16 Sep 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout late
Indicative materiality
High rules
Action
Report
Language
Expected (“expects”, “plans”)

How this entry was checked

  1. Commitment recordedRecorded from the company's filing.
  2. First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Eton Pharmaceuticals, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2025-ETON-000398 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.